Addressing and Advancing the Problem of Missing Data

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.19, Iss.6, 2009-11, pp. : 945-956

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Missing Data—Prevention and Analysis

By Soon Guoxing

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 941-944

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data in Biologic Oncology Products

By Rothmann Mark Koti Kallappa Lee Kyung Yul Lu Hong Laura Shen Yuan Li

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 1074-1084

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data in the Regulation of Medical Devices

By Campbell Gregory Pennello Gene Yue Lilly

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 180-195

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data in Confirmatory Clinical Trials

By Flyer Paul Hirman Joseph

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 969-979

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Inaction: Preventing Missing Outcome Data in Randomized Clinical Trials

By Wittes Janet

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 957-968

Taylor & Francis Ltd

Access to resources Recommend Favorite